25% of Hong Kong employers plan to cut staff in next quarter: survey
About 25 per cent of Hong Kong employers plan to cut staff in the next quarter, according to a human resources company's survey, as the latest government figures showed the city's unemployment rate reached a 30-month high of 3.5 per cent for March to May.
Workforce solutions provider ManpowerGroup Greater China released its latest employment outlook survey on Tuesday, with about 33 per cent of the 522 employers polled saying they expected to hire more personnel in the next three months.
About 25 per cent of respondents anticipated job cuts, while around 41 per cent foresaw no change in staff numbers.
ManpowerGroup also compiled a Net Employment Outlook (NEO) index for Hong Kong, which was calculated by subtracting the percentage of employers that anticipated manpower cuts from those expecting an increase.
The city's index stood at 8 per cent for the third quarter, down from 11 per cent in the last quarter and contrasting with an international level of 24 per cent for the next three months.
Lancy Chui Yuk-shan, senior vice-president of the company, said: 'Overall, Hong Kong's job market is facing multiple challenges, including the slowdown in the global economy and geopolitical pressures.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
27 minutes ago
- South China Morning Post
MingMed seeks Hong Kong listing to fund research and launch Botox alternative
MingMed Biotechnology is seeking a Hong Kong listing this year to raise funds to research and market a genetically engineered alternative to Botox in China. The drug developer, based in the Nansha district of Guangzhou, said it would set up an incubation centre in the Hong Kong Science and Technology Park in the third quarter. 'Hong Kong has many good universities and research institutes, but it [does not have] a lot of innovative biotech firms,' said MingMed CEO Zhang Yan in an interview on Friday. 'We aim to [turn] early-stage research discoveries at the city's universities into commercial products.' He said Hong Kong was a good platform for fundraising , early-stage drug research and global commercialisation, while Nansha was an ideal location for research and manufacturing. MingMed has raised 1.75 billion yuan (US$243.7 million) from multiple private fundraisings, Zhang said, adding that its largest institutional investor was Beijing-based Gaorong Ventures. The company filed a Hong Kong listing application in 2022, but let it lapse due to unfavourable global market conditions for biotech stocks, he said. Last year, MingMed completed a late-stage, phase-three clinical trial on a genetically manipulated alternative to Botox, which is used to reduce wrinkles. Botox is made from a naturally occurring botulinum toxin, a protein produced by a bacterium. Genetically engineered products could lower production costs and enhance product safety, Zhang said.
South China Morning Post
an hour ago
- South China Morning Post
China condemns US ‘malign influence' over Panama's plan to replace Huawei towers
Following a US announcement of a project in Panama to replace communications towers installed by Chinese telecoms giant Huawei Technologies, Beijing has condemned what it calls Washington's 'malign influence' in Latin America. Chinese Foreign Ministry spokesman Guo Jiakun said on Monday that the region was 'not the backyard of anyone' and accused the US of 'politicising economic, trade and scientific and technological issues'. He rejected US claims that Huawei's equipment posed any national security threat and said that China's dealings with countries in Latin America and the Caribbean were built on 'mutual respect'. The statement was a response to an announcement by the US embassy in Panama promoting a new US$8 million initiative to replace Huawei telecoms equipment with 'secure American technology' at 13 sites in the country. Nor was China alone in its discontent. Last week, Panamanian President José Raúl Mulino spoke at length about liberties he said the US embassy had taken in announcing the project. Developed in coordination with Panama's Ministry of Public Security, the plan includes the installation of seven new towers across four provinces.
South China Morning Post
an hour ago
- South China Morning Post
Hong Kong's CK Hutchison ports sale on thin ice amid US-China tensions: analysts
The US$23 billion sale of global port stakes by Hong Kong's CK Hutchison could be subject to substantial changes if it is not already on the verge of collapse, with Chinese and Panamanian authorities possibly rejecting the terms, legal and logistics experts have said ahead of the deal's deadline for exclusive negotiation. Their analysis followed national security and anti-monopoly concerns cited by both countries, with a recent news report suggesting that a state-owned shipping company was now involved in the negotiation to ease Beijing's concerns. The deal , which includes the Balboa and Cristobal ports at both ends of the Panama Canal, was caught in the crossfire of geopolitical tensions between the United States and China just weeks before a crucial July 27 exclusive negotiation deadline. The transaction involves CK Hutchison Holdings selling stakes in 43 ports to a consortium led by Terminal Investment Limited, an affiliate of the world's largest container line MSC, and US asset management giant BlackRock and Global Infrastructure Partners. 'The deal regarding price, due diligence and financing is basically done. What remains are the signoffs from the Panamanian and mainland authorities,' said Surinder Brrar, a professor of practice in global shipping and logistics at Polytechnic University. He described these approvals as 'big hurdles' that could derail the entire transaction if not surmounted.
